Medical Xpress February 10, 2025
Gordy Slack, Stanford University

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that occur within a U.S. hospital. It happens due to a dysregulated immune response to infection, and its high mortality rate correlates to the difficulty in quickly diagnosing and appropriately addressing the origin of infection, be it bacterial, viral, or some other pathogen. Current methods can delay that life-or-death determination for as long as three days.

Enter the Stanford Medicine lab of Purvesh Khatri, where a test developed to reduce that time frame to roughly 30 minutes—an advancement that could be transformative for millions of patients each year—was cleared by the Food and Drug Administration in January.

Khatri, Ph.D., a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Health System / Hospital, Provider
Finally, FDA’s Final Word on Unapproved Use Communications
Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval
“Precision Med Has Evolved as Badly As I Expected” And Other Takeaways From Former FDA Commissioner At PMWC
FDA approves clinical trials for pig organ transplants
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA

Share This Article